Ropinirole Hcl
Brand name: Ropinirole Hcl
Rank #360 of 500 drugs by total cost
$27.5M
Total Cost
1,204,903
Total Claims
$27.5M
Total Cost
38,496
Prescribers
$23
Cost per Claim
119,336
Beneficiaries
2,207,475
30-Day Fills
$713
Avg Cost/Provider
31
Avg Claims/Provider
About Ropinirole Hcl
Ropinirole Hcl (sold as Ropinirole Hcl) was prescribed 1,204,903 times by 38,496 Medicare Part D providers in 2023, costing the program $27.5M. At $23 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 357 | Fostemsavir Tromethamine (Rukobia) | $27.8M | 3,094 |
| 358 | Colchicine (Colchicine) | $27.5M | 314,046 |
| 359 | Valsartan/Hydrochlorothiazide (Valsartan-Hydrochlorothiazide) | $27.5M | 510,583 |
| 360 | Ropinirole Hcl (Ropinirole Hcl) | $27.5M | 1,204,903 |
| 361 | Trifluridine/Tipiracil Hcl (Lonsurf) | $27.3M | 2,430 |
| 362 | Memantine Hcl/Donepezil Hcl (Namzaric) | $27.2M | 46,134 |
| 363 | Solifenacin Succinate (Solifenacin Succinate) | $27.1M | 343,174 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology